Geode Capital Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Geode Capital Management’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-915	Closed	-$18K	–	5046
2022 Q2	$18K	Hold	915	–	–	﹤0.01%	4941
2022 Q1	$33K	Hold	915	–	–	﹤0.01%	4888
2021 Q4	$32K	Hold	915	–	–	﹤0.01%	4916
2021 Q3	$68K	Buy	915 +384	+72%	+$27.3K	﹤0.01%	4747
2021 Q2	$46K	Hold	531	–	–	﹤0.01%	4667
2021 Q1	$60K	Buy	531 +292	+122%	+$32.4K	﹤0.01%	4384
2020 Q4	$10K	Hold	239	–	–	﹤0.01%	4266
2020 Q3	$8K	Hold	239	–	–	﹤0.01%	4152
2020 Q2	$19K	Hold	239	–	–	﹤0.01%	4072
2020 Q1	$12K	Hold	239	–	–	﹤0.01%	4071
2019 Q4	$21K	Hold	239	–	–	﹤0.01%	4154
2019 Q3	$24K	Hold	239	–	–	﹤0.01%	4131
2019 Q2	$70K	Buy	+239	New	+$84.2K	﹤0.01%	4021
2015 Q4	–	Sell	-1	Closed	-$1K	–	4153
2015 Q3	$1K	Hold	1	–	–	﹤0.01%	4124
2015 Q2	$3K	Hold	1	–	–	﹤0.01%	3957
2015 Q1	$6K	Hold	1	–	–	﹤0.01%	3947
2014 Q4	$6K	Hold	1	–	–	﹤0.01%	3973
2014 Q3	$15K	Buy	+1	New	+$12.8K	﹤0.01%	3908

Other funds holding CSCI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management's CSCI Position: Q3 2022 in Review

Geode Capital Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2022, closing a stake of 915 shares — an estimated $18K sold.

Geode Capital Management first reported a position in CSCI in Q3 2014 and held it in 18 quarters. The position peaked at $70K in Q2 2019. 12 funds tracked by Wall St. Rank hold CSCI as of Q3 2022.

Geode Capital Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Geode Capital Management sold 915 COSCIENS Biopharma Inc. Common Stock shares in Q3 2022, an estimated $18K.
Geode Capital Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q3 2014 and held it in 18 quarters.
Geode Capital Management's COSCIENS Biopharma Inc. Common Stock position peaked at $70K in Q2 2019.
12 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2022.

Based on Geode Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.